• CONTACT US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ABOUT US
    • CORPORATE HISTORY –
    • BUSINESS PARTNERSHIPS –
    • QUALITY CONTROL & QUALITY ASSURANCE –
    • MANUFACTURING EXPERTISE –
    • MARKETING & SALES –
  • OUR DIVISIONS
    • PHARMA HEALTH DIVISION –
    • ANIMAL HEALTH DIVISION –
    • BIO-LABS CONSUMER HEALTH
  • PRODUCTS
    • ALL FEATURED BRANDS
    • PHARMA HEALTH PRODUCTS LIST
    • ANIMAL HEALTH PRODUCTS LIST
  • GLOBAL PRESENCE –
  • BIO-LABS SUBSIDIARIES –
    • Bio-Next Pharmaceuticals –
    • Bio-Labs Consumer Health –
    • ZH Therapeutics –
  • CSR –
  • NEWS & PRESS –
  • CAREERS –
  • CONTACT
0
  • Home
  • News
  • Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division
Bio-Labs Presents Most Effective, FDA Approved Combo for Covid-19 “Bioxovid” – (Nirmatrelvir + Ritonavir)
February 8, 2022
February 14, 2022

Bio-Labs added a new product to the psychiatry division, Qualey (Quetiapine Fumarate). Bio-Labs is pleased and honored to help people take a step “Towards the Peak of Stability” through this product.

Around 50 million people struggle with mental disorders in Pakistan, and Qualey is their solution. It’s an FDA approved atypical antipsychotic that is ideal for treating Schizophrenia and Bipolar Disorder. In addition, it offers high efficacy with lesser side effects than other atypical antipsychotics.

Share

Related posts

February 8, 2022

Bio-Labs Presents Most Effective, FDA Approved Combo for Covid-19 “Bioxovid” – (Nirmatrelvir + Ritonavir)


Read more
January 18, 2022

Ambassador of Azerbaijan H.E. Khazar Farhadov visits the manufacturing plant of Bio-Labs


Read more
January 8, 2022

Bio-Labs Has Successfully Launched another Prime Life-Saving Drug: Merobio (Meropenem)


Read more

 

Bio-Labs is an innovative healthcare company expert in manufacturing and quality control of high-end pharmaceutical products.

  • Contact US: +92 51 8738362-5
  • EMAIL: [email protected]
  • ADDRESS: ISLAMABAD, PAKISTAN

QUICK LINKS

  • HOME
  • CORPORATE HISTORY
  • PHARMA HEALTH DIVISION
  • ANIMAL HEALTH DIVISION
  • PRODUCTS
  • NEWS & PRESS
  • CAREERS
  • CONTACT

RECENT POST

  • 0
    Bio-Labs successfully launched Qualey (Quetiapine Fumarate) in it’s Psychiatry Division
    February 14, 2022
  • 0
    Bio-Labs Presents Most Effective, FDA Approved Combo for Covid-19 “Bioxovid” – (Nirmatrelvir + Ritonavir)
    February 8, 2022
  • 0
    Ambassador of Azerbaijan H.E. Khazar Farhadov visits the manufacturing plant of Bio-Labs
    January 18, 2022

BIO-LABS SISTER CONCERNS

  • Bio-Next Pharmaceuticals
  • Bio-Labs Consumer Health
  • ZHTherapeutics
Copyrights © 2022 Bio-Labs | All rights reserved.